Literature DB >> 17273817

Purification and characterization of rhodobactin: a mixed ligand siderophore from Rhodococcus rhodochrous strain OFS.

Suraj Dhungana1, Ryszard Michalczyk, Hakim Boukhalfa, Joseph G Lack, Andrew T Koppisch, Jason M Fairlee, Mitchell T Johnson, Christy E Ruggiero, Seth G John, Matthew M Cox, Cindy C Browder, Jennifer H Forsythe, Laura A Vanderberg, Mary P Neu, Larry E Hersman.   

Abstract

The siderophore produced by Rhodococcus rhodochrous strain OFS, rhodobactin, was isolated from iron-deficient cultures and purified by a combination of XAD-7 absorptive/partition resin column and semi-preparative HPLC. The siderophore structure was characterized using 1D and 2D (1)H, (13)C and (15)N NMR techniques (DQFCOSY, TOCSY, NOESY, HSQC and LR-HSQC) and was confirmed using ESI-MS and MS/MS experiments. The structural characterization revealed that the siderophore, rhodobactin, is a mixed ligand hexadentate siderophore with two catecholate and one hydroxamate moieties for iron chelation. We further investigated the effects of Fe concentrations on siderophore production and found that Fe limiting conditions (Fe concentrations from 0.1 microM to 2.0 microM) facilitated siderophore excretion. Our interests lie in the role that siderophores may have in binding metals at mixed contamination sites (containing metals/radionuclides and organics). Given the broad metabolic capacity of this microbe and its Fe scavenging ability, R. rhodochrous OFS may have a competitive advantage over other organisms employed in bioremediation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273817     DOI: 10.1007/s10534-006-9079-y

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  7 in total

1.  Structural characterization of amphiphilic siderophores produced by a soda lake isolate, Halomonas sp. SL01, reveals cysteine-, phenylalanine- and proline-containing head groups.

Authors:  Luis O'mar Serrano Figueroa; Benjamin Schwarz; Abigail M Richards
Journal:  Extremophiles       Date:  2015-10-06       Impact factor: 2.395

2.  The intracellular pathogen Rhodococcus equi produces a catecholate siderophore required for saprophytic growth.

Authors:  Raúl Miranda-CasoLuengo; John F Prescott; José A Vázquez-Boland; Wim G Meijer
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

3.  The hydroxamate siderophore rhequichelin is required for virulence of the pathogenic actinomycete Rhodococcus equi.

Authors:  Raúl Miranda-Casoluengo; Garry B Coulson; Aleksandra Miranda-Casoluengo; José A Vázquez-Boland; Mary K Hondalus; Wim G Meijer
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

4.  Genomic and phenotypic analysis of siderophore-producing Rhodococcus qingshengii strain S10 isolated from an arid weathered serpentine rock environment.

Authors:  Irina V Khilyas; Alyona V Sorokina; Maria I Markelova; Maksim Belenikin; Lilia Shafigullina; Rezeda I Tukhbatova; Elena I Shagimardanova; Jochen Blom; Margarita R Sharipova; Michael F Cohen
Journal:  Arch Microbiol       Date:  2020-10-06       Impact factor: 2.552

5.  Intertwined Precursor Supply during Biosynthesis of the Catecholate-Hydroxamate Siderophores Qinichelins in Streptomyces sp. MBT76.

Authors:  Jacob Gubbens; Changsheng Wu; Hua Zhu; Dmitri V Filippov; Bogdan I Florea; Sébastien Rigali; Herman S Overkleeft; Gilles P van Wezel
Journal:  ACS Chem Biol       Date:  2017-10-02       Impact factor: 5.100

Review 6.  Novel Insights on Pyoverdine: From Biosynthesis to Biotechnological Application.

Authors:  Filippo Dell'Anno; Giovanni Andrea Vitale; Carmine Buonocore; Laura Vitale; Fortunato Palma Esposito; Daniela Coppola; Gerardo Della Sala; Pietro Tedesco; Donatella de Pascale
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

Review 7.  Biotechnology of Rhodococcus for the production of valuable compounds.

Authors:  Martina Cappelletti; Alessandro Presentato; Elena Piacenza; Andrea Firrincieli; Raymond J Turner; Davide Zannoni
Journal:  Appl Microbiol Biotechnol       Date:  2020-09-12       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.